IDXG 0.85 (-68.52%)
US46062X3035• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. IDXG

Interpace Biosciences (IDXG) Competitor Comparison

We are evaluating the key criteria listed to compare Interpace Biosciences (IDXG) against its competitors in the Diagnostics & Research industry.

Market Capitalization

57 / 58

Gross Profits

45 / 52

Total Revenue

45 / 57

EBITDA

27 / 56

Free Cashflow

28 / 56

Quick Ratio

50 / 57

Earnings per Share

19 / 55

Dividend yield

0 / 8

Total Cash

52 / 57

Performance 3 years

53 / 58

Performance 5 years

50 / 58

Performance 10 years

57 / 58

Linearity 3 years

49 / 58

Linearity 5 years

41 / 58

Linearity 10 years

42 / 58

Total Rank

17 / 58

Dividend Rank

12 / 58

Valuation Rank

49 / 58

Piotroski Rank

22 / 58

Muliplier Rank

4 / 58

Linearity 5 years - IDXG ranking 41 / 58

These are the competitors of Interpace Biosciences in the industry Diagnostics & Research ranked by linearity 5 years
1. CareDx CDNA
130.64
2. Co-Diagnostics CODX
100.26
3. Ortho Clinical Diagnostics Holdings OCDX
33.4
4. DarioHealth DRIO
31.71
5. Inotiv NOTV
26.98
6. Syneos Health SYNH
24.79
7. Fulgent Genetics FLGT
18.54
8. Charles River Laboratories CRL
16.45
9. Heska HSKA
15.42
10. Icon ICLR
9.52
11. Pacific Biosciences of California PACB
8.97
12. IQVIA Holdings IQV
8.64
13. DexCom DXCM
8.62
14. Olink Holding OLK
8.53
15. Qiagen QGEN
7.4
16. Anixa Biosciences ANIX
6.44
17. Aspira Womens Health AWH
5.9
18. Exact Sciences EXAS
5.7
19. IDEXX Laboratories IDXX
5.58
20. Mettler-Toledo MTD
5
21. PerkinElmer PKI
4.97
22. Trinity Biotech TRIB
4.91
23. Quest Diagnostics DGX
4.73
24. NeoGenomics NEO
4.54
25. Agilent Technologies A
4.39
26. Twist Bioscience TWST
4.19
27. Myriad Genetics MYGN
4.11
28. Laboratory Corp of America Holdings LH
4.04
29. Personalis PSNL
4.04
30. Sera Prognostics SERA
3.99
31. Thermo Fisher Scientific TMO
3.97
32. Illumina ILMN
3.88
33. Guardant Health GH
3.8
34. Danaher DHR
3.74
35. Sotera Health SHC
3.69
36. Enzo Biochem ENZ
3.59
37. Neogen NEOG
3.52
38. Waters WAT
3.38
39. Bioventus BVS
2.78
40. National Research NRC
2.7
41. Interpace Biosciences IDXG
2.45
42. Precipio PRPO
2.41
43. Neuronetics STIM
2.28
44. Psychemedics PMD
2.24
45. Global Cord Blood CO
2.23
46. MaxCyte MXCT
2.13
47. MDxHealth MDXH
2.01
48. Biodesix BDSX
1.91
49. Prenetics Global PRE
1.78
50. Exagen XGN
1.76
51. bioAffinity Technologies BIAF
1.67
52. Organovo Holdings ONVO
1.6
53. SeqLL SQL
1.38
54. Meridian Bioscience VIVO
0.99
55. Medpace Holdings MEDP
0.62
56. Natera NTRA
0.58
57. RadNet RDNT
0.39
58. Lantheus Holdings LNTH
0.39
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.